The use of patient-reported outcome measures to guide referral for hip and knee replacement: Part 2 – a cost-effectiveness analysis
DAKIN H. et al, (2020), Bone and Joint Journal
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Reed SD. et al, (2020), Diabetes Care, dc190950 - dc190950
Cooled radiofrequency ablation of the genicular nerves for chronic pain due to osteoarthritis of the knee: a cost-effectiveness analysis based on trial data.
Desai M. et al, (2019), BMC Musculoskelet Disord, 20
The Arthroplasty Candidacy Help Engine tool to select candidates for hip and knee replacement surgery: development and economic modelling.
Price A. et al, (2019), Health technology assessment (Winchester, England), 23, 1 - 216
Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? An early cost-utility analysis.
ABEL L. et al, (2019), International Journal of Technology Assessment in Health Care
Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL
Reed SD. et al, (2018), DIABETOLOGIA, 61, S426 - S426
Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
Becker F. et al, (2018), DIABETOLOGIA, 61, S366 - S366
Partial factorial trials: Comparing methods for statistical analysis and economic evaluation
Dakin HA. et al, (2018), Trials
EXSCEL-Once-Weekly Exenatide Reduces Medical Resource Utilization in Patients with Type 2 Diabetes Mellitus
Reed SD. et al, (2018), DIABETES, 67
Decision-making for healthcare resource allocation: Joint versus separate decisions on interacting intervention
Dakin HA. and Gray A., (2018), Medical Decision Making
Associations between preoperative Oxford hip and knee scores and costs and quality of life of patients undergoing primary total joint replacement in the NHS England: an observational study.
Eibich P. et al, (2018), BMJ open, 8, e019477 - e019477
Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement
Dakin HA. et al, (2018), Health and Quality of Life Outcomes
Economic evaluation of factorial randomised controlled trials: Challenges, methods and recommendations
Dakin HA. and Gray A., (2017), Statistics in Medicine
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial.
Reeves BC. et al, (2016), Health Technol Assess, 20, 1 - 120
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial
Reeves BC. et al, (2016), Health technology assessment (Winchester, England), 20, 1 - 120
Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3L.
Dixon P. et al, (2016), Qual Life Res, 25, 935 - 945
Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement
Petrou S. et al, (2016), Quality of Life Research, 25, 275 - 281